Longevity investing

Longevity TV

The Juvenescence business model and future of anti-aging

Phil Newman - 0
Greg Bailey, CEO, Juvenescence
Read more
Longevity 2020

Global pandemics & accelerated investment in Longevity

Phil Newman - 0
Dmitry Kaminskiy, Co-founder / Managing Partner, Deep Knowledge Ventures / Longevity.Capital / Deep Knowledge Analytics.
Read more
Longevity TV

The crucial question in Longevity investing: is it repair?

Phil Newman - 0
Reason, Co-founder and CEO, Repair Biotechnologies & Fight Aging!
Read more
Longevity TV

Genome editing: opportunity & anxiety in equal measure

Phil Newman - 0
James Lawford Davies, Partner, Hill Dickinson
Read more
Longevity TV

From science fiction to FDA submission: ectopic organoids & the commercialization of regenerative medicine

Phil Newman - 0
Michael Hufford, Co-Founder and CEO, LyGenesis
Read more
Longevity TV

How to identify new targets and indications for aging drug development

Phil Newman - 0
Simon Melov, Professor, Buck Institute and Founder and CEO, Gerostate Alpha
Read more
Longevity TV

Risk & reward: Longevity investments

Phil Newman - 0
Ronjon Nag, Managing Director and Founder, R42 Group
Read more
Longevity 2020

5 investment lessons from coronavirus

Phil Newman - 0
Sergey Young, Founder, Longevity Vision Fund.
Read more
Longevity TV

‘Longevity investing’ Ask Me Anything

Phil Newman - 0
Various speakers from the conference come together to answer your questions on Longevity investing.
Read more

Latest articles

Selfie biomarkers: AI and insurtech implications for Longevity

AI Danny Sullivan - 0
AI firm Lapetus targets the face as a biomarker of aging: one simple picture can open-up a host of opportunities and implications. Wow. Named after...
Read more

Low levels of stress hormone contributes to aging

Cellular Carla Heyworth - 0
When it comes to the stress hormone cortisol, balance is everything, according to a new study in Germany.  There have been plenty of studies that...
Read more

Rejuvenation Roadmap charts life extension progress

Senescence Eleanor Garth - 0
We take a trip down Lifespan.io's Rejuvenation Roadmap – and it's a journey towards Longevity progress. Lifespan.io is a US-based non-profit organisation that seeks to...
Read more

Longevity therapies delivered through skin is a topical issue

Senolytic drugs Eleanor Garth - 0
Non-invasive therapy that comes in a bottle could be the Longevity crème de la crème. Therapeutic substances like arnica, turmeric and witch hazel have been...
Read more
TISSUE/ORGAN | NANOTECH | SENESCENCE | CELLULAR | DRUGS | AI | NEURAL | AGETECH | INVESTMENT

LONGEVITY MARKET | ABOUT US | MY ACCOUNT | SHARE YOUR NEWS | CONTACT US

PRIVACY POLICY | COOKIE POLICY | TERMS AND CONDITIONS | COPYRIGHT POLICY

© Copyright 2020 PERGALI Limited. All rights reserved. PERGALI, Longevity.Technology and their associated logos are trademarks of PERGALI Limited and are the subject of trademark applications or registrations in various countries around the world. All other trademarks are the property of their respective owners. All PERGALI products and services are subject to continuous development. We reserve the right to alter technical specifications without prior notice.